Search

Your search keyword '"Adenolymphoma diagnostic imaging"' showing total 246 results

Search Constraints

Start Over You searched for: Descriptor "Adenolymphoma diagnostic imaging" Remove constraint Descriptor: "Adenolymphoma diagnostic imaging"
246 results on '"Adenolymphoma diagnostic imaging"'

Search Results

1. Multi-feature Fusion Network on Gray Scale Ultrasonography: Effective Differentiation of Adenolymphoma and Pleomorphic Adenoma.

2. An ultrasound-based ensemble machine learning model for the preoperative classification of pleomorphic adenoma and Warthin tumor in the parotid gland.

3. Management for Warthin Tumor of the Parotid Gland: Surgery or Observation. A 21-Year Retrospective Study of 387 Cases.

4. Fine needle aspiration diagnosis of benign oncocytic lesions of the head and neck associated with false positive 18 F-fluorodeoxyglucose uptake on positron emission tomography scan.

5. Characterization of parotid gland tumors using diffusion-relaxation correlation spectrum imaging: a preliminary study.

6. Multispectral optoacoustic tomography of benign parotid tumors in vivo: a prospective observational pilot study.

7. Evaluation of Quantitative Dual-Energy Computed Tomography Parameters for Differentiation of Parotid Gland Tumors.

8. Differentiation of salivary gland tumours using diffusion-weighted image-based virtual MR elastography: a pilot study.

9. [Imaging findings in 12 cases of Warthin-like mucoepidermoid carcinoma].

10. Differentiation of parotid pleomorphic adenoma from Warthin tumor using signal intensity ratios on fat-suppressed T2-weighted magnetic resonance imaging.

11. Fine needle aspiration as a diagnostic modality for Warthin tumors identified as fluorodeoxyglucose positron emission tomography/computed tomography-positive.

12. A Safety and Feasibility Trial of Ultrasound-Guided Radiofrequency Ablation of Parotid Warthin's Tumor.

13. A nomogram incorporating clinical, conventional ultrasound and shear wave elastography findings for distinguishing pleomorphic adenoma from Warthin's tumor of the major salivary glands.

14. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.

15. Distinguishing Parotid Polymorphic Adenoma and Warthin Tumor Based on the CT Radiomics Nomogram: A Multicenter Study.

16. Concurrent Warthin tumor and Kimura disease: a case report.

17. Enhanced CT-based texture analysis and radiomics score for differentiation of pleomorphic adenoma, basal cell adenoma, and Warthin tumor of the parotid gland.

18. Perfusion analysis of benign parotid gland tumors by contrast-enhanced ultrasonography (CEUS).

19. Synchronous bilateral multifocal basal cell adenomas of the parotid gland-a case report.

20. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.

21. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.

22. Experience with follow-up strategy in selected patients with Warthin tumour diagnosed by ultrasound-guided fine-needle aspiration biopsy (FNAB).

23. Influence of post-label delay time on the performance of 3D pseudo-continuous arterial spin labeling magnetic resonance imaging in the characterization of parotid gland tumors.

24. Diffusion-weighted imaging with histogram analysis of the apparent diffusion coefficient maps in the diagnosis of parotid tumours.

25. Parotid Warthin's tumor: novel MR imaging score as diagnostic indicator.

27. Efficacy of computed tomography features in the differentiation of basal cell adenoma and Warthin tumor in the parotid gland.

28. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation.

29. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging.

30. [Performance of the magnetic resonance imaging in parotid gland tumor histopathology].

31. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.

32. Conventional, diffusion, and dynamic contrast-enhanced MRI findings for differentiating metaplastic Warthin's tumor of the parotid gland.

33. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.

34. Differentiating malignant from benign salivary gland lesions: a multiparametric non-contrast MR imaging approach.

35. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.

36. Clinical Utility of Qualitative Elastography Using Acoustic Radiation Force Impulse for Differentiating Benign from Malignant Salivary Gland Tumors.

37. Warthin Tumor Incidentally Detected on PET/CT Showing Both 68Ga-DOTANOC and 18F-FDG Uptake.

38. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.

40. Differentiation of salivary gland tumors through tumor heterogeneity: a comparison between pleomorphic adenoma and Warthin tumor using CT texture analysis.

41. MRI-based texture analysis to differentiate the most common parotid tumours.

42. Characteristics of pleomorphic adenomas, adenolymphomas, and malignant tumors of the salivary glands on color doppler ultrasonography and contrast enhanced ultrasonography.

43. The diagnostic value of Superb Microvascular Imaging in identifying benign tumors of parotid gland.

44. The role of diffusion-weighted and dynamic contrast enhancement perfusion-weighted imaging in the evaluation of salivary glands neoplasms.

45. Differentiation of salivary gland tumor using diffusion-weighted imaging with a fractional order calculus model.

46. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.

47. Improving the diagnosis of common parotid tumors via the combination of CT image biomarkers and clinical parameters.

48. Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer.

49. Juvenile sclerosing polycystic adenosis cytologically mimicking Warthin tumor.

50. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.

Catalog

Books, media, physical & digital resources